Remus Scripts a New Chapter—Launches Trial Material Subsidiary with Precision Dose

Unknown Apr 02, 2026 1,800 Views

Ahmedabad, India, June 20, 2025 — Remus Pharmaceuticals Ltd. (REMP.NS) today announced the formation of a new clinical trial material management subsidiary as a strategic expansion into the high-growth clinical research support industry. The new business will be specialized i...